Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 17, 2022

SELL
$19.97 - $26.94 $95,856 - $129,312
-4,800 Reduced 6.97%
64,100 $1.66 Million
Q4 2021

Feb 15, 2022

SELL
$17.46 - $21.61 $319,518 - $395,463
-18,300 Reduced 20.99%
68,900 $1.41 Million
Q3 2021

Nov 16, 2021

BUY
$17.35 - $22.5 $635,010 - $823,500
36,600 Added 72.33%
87,200 $1.68 Million
Q2 2021

Aug 16, 2021

BUY
$18.01 - $28.32 $689,783 - $1.08 Million
38,300 Added 311.38%
50,600 $1.12 Million
Q1 2021

May 18, 2021

BUY
$19.76 - $29.89 $39,520 - $59,780
2,000 Added 19.42%
12,300 $323,000
Q4 2020

Feb 17, 2021

SELL
$15.73 - $21.66 $4,719 - $6,498
-300 Reduced 2.83%
10,300 $193,000
Q2 2020

Aug 17, 2020

BUY
$7.84 - $23.29 $83,104 - $246,874
10,600 New
10,600 $247,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.